Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

An End to Drug Errors?

August 29, 2014 8:30 am | News | Comments

MIT alumni have devised the MedEye, a bedside medication-scanning system that uses computer vision to identify pills and check them against medication records, to ensure that a patient gets the right drug and dosage. Read more...       

TOPICS:

Synthetic Biologics Improves Enzyme for C.diff Prevention

August 29, 2014 8:30 am | News | Comments

Synthetic Biologics, Inc. and FUJIFILM Diosynth Biotechnologies UK Limited have announced confirmation of exceptional results from the initial phase of cGMP manufacturing of SYN-004, Synthetic Biologics' proprietary oral beta-lactamase enzyme for the prevention of Clostridium difficile (C. difficile) infections. Read more...

TOPICS:

GSK-NIH Ebola Vaccine to Enter Safety Testing

August 28, 2014 2:00 pm | by Seth Borenstein, AP Science Writer | News | Comments

Federal researchers next week will start testing humans with an experimental vaccine to prevent the deadly Ebola virus. The NIH announced today that it is launching the safety trial on a vaccine developed by the agency's National Institute of Allergy and Infectious Diseases and GSK. Read more...

TOPICS:
Advertisement

New Drug Ups OS in Stage III Colon Cancer

August 28, 2014 2:00 pm | News | Comments

A subset of patients with Stage III colon cancer had improved survival rates when treated with irinotecan-based therapy, according to a new study. Read more...                          

TOPICS:

Compound Promises Relief for Inflammatory Pain

August 28, 2014 2:00 pm | News | Comments

Researchers have discovered that a compound they developed could potentially serve as a painkiller, with particular utility for East Asians with an alcohol-metabolizing enzyme mutation. Read more...                

TOPICS:

HIV Drug Dosage May Be Ineffective for African-Americans

August 28, 2014 2:00 pm | News | Comments

Many African-Americans may not be getting effective doses of the HIV drug maraviroc, a new study suggests. The initial dosing studies, completed before the drug was licensed in 2007, included mostly European-Americans, who generally lack a protein that is key to removing maraviroc from the body. Read more...

TOPICS:

Researchers Investigating New MS Treatment

August 28, 2014 2:00 pm | News | Comments

A new treatment under investigation for multiple sclerosis (MS) is safe and tolerable in Phase 1 clinical trials, according to a new study. The Phase 1 studies were the first to test the drug candidate in humans. Read more...     

TOPICS:

High-Performance, Multi-Position Reaction Block

August 28, 2014 10:24 am | Product Releases | Comments

The DrySyn MULTI from Asynt converts any standard hotplate stirrer into a high performance reaction block accommodating 3 round-bottomed flasks or up to 12 reactions in tubes or vials.

Advertisement

ChIP Sequencing Kit for NGS

August 28, 2014 10:17 am | Product Releases | Comments

The ChIP sequencing assay kit from Porvair Sciences extends the benefits of their proprietary Chromatrap solid state ChIP technology to preparation of purified Chromatin for the generation of sequencing libraries.

Fraction Collection Storage Solution

August 28, 2014 10:08 am | Product Releases | Comments

A complete storage solution for HPLC fractions is available from Porvair Sciences, comprised of the company's 2ml round deep well microplate and high integrity cap mat seals.

Two-Drug Combo Speeds Wound Healing, Reduces Scar Tissue

August 28, 2014 9:53 am | News | Comments

A combination of two drugs already approved by the U.S. Food and Drug Administration for different applications reduces wound healing time by one-quarter and significantly decreases scar tissue in mice and rats, researchers report. Read more...     

TOPICS:

FDA Approves Generic Megace from TWi

August 28, 2014 9:45 am | News | Comments

TWi Pharmaceuticals Inc. announced that it has received final approval from the FDA on its Abbreviated New Drug Application for megestrol acetate 125mg/ml oral suspension, the generic equivalent to Par Pharmaceutical's Megace ES. Read more...   

TOPICS:

Daiichi Sankyo Signs Hep B Vaccine Agreement

August 28, 2014 9:40 am | News | Comments

Daiichi Sankyo Co. Ltd. announced that it has signed a cooperative sales agreement with The Chemo-Sero-Therapeutic Research Institute  for its recombinant adsorbed hepatitis B vaccine (yeast-derived), Bimmugen. Read more...       

TOPICS:

UN: Ebola Cases Could Reach 20,000

August 28, 2014 9:34 am | by John Heilprin and Krista Larson | News | Comments

The Ebola outbreak in West Africa eventually could exceed 20,000 cases, more than six times as many as are now known, the World Health Organization said Thursday. Read more...                      

TOPICS:

The Future of Genome Analysis

August 28, 2014 9:30 am | by Maxim Mikheev, M.D., Ph.D., Co-Founder and Chief Technical Officer at BioDatomics | Articles | Comments

As technological improvements have changed the way we study the genome, the amount of data associated with a single DNA sample has increased exponentially. Surprisingly, throughout this evolution the hardware and software infrastructure supporting bioanalytics has barely changed. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading